Targeted lysosomal activation in bladder epithelium enhances clearance of intracellular uropathogenic Escherichia coli
Open Access
- 25 September 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 22 (9) , e1014448
Abstract
Recurrent urinary tract infections (UTIs) are a major clinical burden, driven in part by the ability of uropathogenic Escherichia coli (UPEC) to establish intracellular niches within the bladder epithelium, where bacteria withstand antibiotics and host defenses. The oral bacterial lysate OM-89 (Uro-Vaxom), a clinically approved and globally used therapy for the prevention and management of recurrent UTIs for several decades, reduces recurrence rates, but its cellular mechanisms of action remain incompletely understood. Here, we demonstrate that OM-89 strengthens antimicrobial defenses in bladder epithelial cells and, in combination with antibiotic therapy, limits post-antibiotic bacterial regrowth in epithelial infection models. OM-89 promotes lysosomal acidification and increases lysosomal protease activity in bladder organoids and differentiated epithelial monolayers, thereby directing intracellular UPEC toward degradative compartments. In parallel, OM-89 enhances intracellular accumulation of multiple antibiotic classes. These effects are conserved across distinct UPEC strains and in both murine and human epithelial models. Our findings demonstrate that bladder epithelial antimicrobial pathways can be pharmacologically reinforced to influence treatment outcomes by enhancing intracellular bacterial clearance.Keywords
Funding Information
- Bundesbehörden der Schweizerischen Eidgenossenschaft (2022.0289)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (TMPFP3_217144)
- IBSA Foundation (IBSA Foundation Fellowships Call 2021 in Fertility/Urology)
- Fondation Leenaards
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (AntiResist grant 51NF40_180541)
- OM Pharma
This publication has 76 references indexed in Scilit:
- Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium/IL-33/ILC2 axisJournal of Allergy and Clinical Immunology, 2021
- Early invasion of the bladder wall by solitary bacteria protects UPEC from antibiotics and neutrophil swarms in an organoid modelCell Reports, 2021
- Collaboration between Distinct Rab Small GTPase Trafficking Circuits Mediates Bacterial Clearance from the Bladder EpitheliumCell Host & Microbe, 2017
- A TRP Channel Senses Lysosome Neutralization by Pathogens to Trigger Their ExpulsionCell, 2015
- LC3 and Autophagy2008
- Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagyMolecular Aspects of Medicine, 2006
- Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitisWorld Journal of Urology, 2005
- A Long-Term, Multicenter, Double-Blind Study of an Escherichia Coli Extract (OM-89) in Female Patients with Recurrent Urinary Tract InfectionsEuropean Urology, 2005
- Biological activity of bacterial cell-wall components: immunogenicity of the bacterial extract OM-89Immunopharmacology, 1995
- Measurement of invasion by gentamicin resistance1994